METiS, an AI Drug Firm, Plans $200 Million IPO in Hong Kong
METiS Pharmaceuticals, an AI-driven drug delivery and discovery firm based in Hangzhou, is exploring the possibility of launching an initial public offering (IPO) in Hong Kong.
METiS
METiS Pharmaceuticals, an AI-driven drug delivery and discovery firm based in Hangzhou, is exploring the possibility of launching an initial public offering (IPO) in Hong Kong.
